Radiotherapy combined with nimotuzumab for elderly esophageal cancer patients: A phase II clinical trial

OBJECTIVE: To investigate the safety and efficacy of nimotuzumab combined with radiotherapy for elderly patients with non-resectable esophageal carcinoma (EC). METHODS: Eligible patients were aged 70 years or older and had treatment-naïve, histologically proven inoperable locally advanced EC. Enroll...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Chin J Cancer Res
Glavni autori: Yang, Xu, Zhai, Yirui, Bi, Nan, Zhang, Tao, Deng, Lei, Wang, Wenqing, Wang, Xin, Chen, Dongfu, Zhou, Zongmei, Wang, Luhua, Liang, Jun
Format: Artigo
Jezik:Inglês
Izdano: AME Publishing Company 2021
Teme:
Original Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7941689/
https://ncbi.nlm.nih.gov/pubmed/33707928
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21147/j.issn.1000-9604.2021.01.06
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items